Compound Radar

Hinge Health, Inc. (HNGE) Stock Analysis

Price $92.69
Market cap $7.48B
Next earnings Nov 3, 2026
Entry status Wait $81.58–$86.62

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

71
71/100 High Quality
  • Financial Health 60
  • Profitability 90
  • Business Quality 65
  • Balance Sheet 65
  • Cash Flow 70

Why this rating?

Health 71/100 — High Quality

Strongest Profitability 90/100
Softest Financial Health 60/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Hinge Health, Inc. (HNGE) is a Health Information Services company in the Healthcare sector. Compound Radar rates Hinge Health, Inc. 71/100 (High Quality) due to solid business quality, strong revenue growth, and manageable leverage.

Investment profile

  • Quality Moderate
  • Growth Strong
  • Balance Sheet Adequate
  • Valuation Fair

Financial highlights

Valuation

  • P/E 11.28
  • Forward P/E 29.62
  • EV/Revenue 9.82

Profitability

  • Revenue Growth 53.0%
  • Gross Margin 84.5%
  • Operating Margin 19.0%
  • Net Margin 15.1%
  • ROE 30.4%

Financial strength

  • Cash $389.39M
  • Debt $5.88M
  • Net Cash $383.51M
  • Free Cash Flow $165.38M
  • Current Ratio 1.34

Similar companies

Peers in Health Information Services, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Health Information Services →

FAQ

How Compound Radar scores and tracks Hinge Health, Inc. (HNGE).

View Methodology & FAQ →